GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Excelsior Biopharma Inc (ROCO:6496) » Definitions » Purchase Of Investment

Excelsior Biopharma (ROCO:6496) Purchase Of Investment : NT$0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Excelsior Biopharma Purchase Of Investment?

Excelsior Biopharma's purchase of investment for the three months ended in Mar. 2025 was NT$0.0 Mil. It means Excelsior Biopharma spent NT$0.0 Mil on purchasing investments. Excelsior Biopharma's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.0 Mil.

Compared with last quarter (NT$0.0 Mil in Dec. 2024 ), Excelsior Biopharma spent the same money on purchasing investments in Mar. 2025 (NT$0.0 Mil).

Excelsior Biopharma Purchase Of Investment Historical Data

The historical data trend for Excelsior Biopharma's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Excelsior Biopharma Purchase Of Investment Chart

Excelsior Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.75 -5.83 - - -55.50

Excelsior Biopharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Excelsior Biopharma Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Biopharma Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Excelsior Biopharma's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Excelsior Biopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Excelsior Biopharma Inc (ROCO:6496) » Definitions » Purchase Of Investment
Comparable Companies
ROCO:6677 ROCO:1780 ROCO:5398 ROCO:4117 ROCO:6483 ROCO:4127 ROCO:4172 ROCO:6935 ROCO:6817 ROCO:8432 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Zhongxiao E. Road, 5Floor, No.508, Sector 7, Nangang District, Taipei, TWN, 11561
Website
http://www.excelsiorgroup.com.tw
Excelsior Biopharma Inc is mainly engaged in western medicines, importing and exporting of Active Pharmaceutical Ingredients, food, cosmecteuticals and development of cosmetics, research, importing, and exporting of technologies, pharmaceutical technologies transfer and cooperative development and improvement. Geographically, it derives revenue from Taiwan, China and others, with majority of revenue earned from Taiwan.

Excelsior Biopharma Headlines

No Headlines